查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974053

口服固体製剂生产市场分析及预测（至2035年）：类型、产品、服务、技术、应用、剂型、材料类型、製程及最终用户

Oral Solid Dosage Manufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Form, Material Type, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 332 Pages | 商品交期: 3-5个工作天内

价格
简介目录

口服固体製剂生产市场预计将从2024年的323亿美元成长到2034年的564亿美元，复合年增长率约为5.7%。口服固体製剂生产市场涵盖稳定、便利且经济高效的药片和胶囊的生产。药物製剂技术的进步、製程优化和法规遵循的提高是推动该行业发展的主要因素。包衣技术、连续生产和个人化医疗的创新正在重塑市场格局。慢性病盛行率的上升和学名药需求的成长是推动市场成长的主要动力，而永续性和品质保证仍然至关重要。

口服固体製剂生产市场正经历强劲成长，这主要得益于技术进步和对高效给药系统日益增长的需求。速释片剂因其应用广泛且服用方便，成为成长最强劲的细分市场。缓释片剂紧跟在后，有助于提高患者依从性和治疗效果。胶囊製剂，尤其是硬胶囊，因其用途广泛且便于患者使用而备受关注。针对吞嚥困难患者的口溶锭的需求也在不断增长。在辅料方面，粘合剂和填充剂因其在製剂稳定性和药物释放方面发挥的关键作用而占据主导地位。包衣材料是第二大成长细分市场，因为它们可以提高药物保护和患者依从性。连续生产技术因其能够提高效率和降低生产成本而发展迅速。对先进品管系统的投资确保了符合严格的监管标准，从而进一步推动了市场成长。

市场区隔
类型 速释片、缓释片、咀嚼片、发泡、口溶锭片、舌下片、膜衣锭、糖衣片、肠溶锭
产品 片剂、胶囊、粉末、颗粒剂、锭剂、丸剂
服务 配方开发、製程开发、分析测试、法规遵循、包装、品质保证、供应链管理
科技 压片、製粒、包衣、封装、冷冻干燥、微粉化、喷雾干燥、连续生产、3D列印
目的 药品、营养补充品、化妆品、生物製药、非处方药、处方药、动物用药品
剂型 固体，固体
材料类型 原料药（API）、辅料、粘合剂、崩坏、润滑剂、着色剂、包衣剂、防腐剂
流程 湿式製粒、干式製粒、直接压片、热熔挤出
最终用户 製药公司、契约製造组织（CMO）、研发实验室

市场概况：

口服固体製剂生产市场呈现市场占有率分布多元化的特点，主要受策略性定价模式和创新产品不断涌现的影响。主要企业正致力于透过先进的製剂和给药技术来强化产品系列。旨在拓展产品线的联盟和伙伴关係进一步加剧了这种竞争格局。定价策略体现了这些创新产品带来的附加价值，并与医疗服务提供者和患者不断变化的需求相契合。口服固体製剂生产市场的竞争异常激烈，主要企业竞相透过创新和策略併购来主导。监管的影响在北美和欧洲等地区尤其显着，这些地区严格的监管准则塑造了市场动态。企业必须遵守这些法规，这反过来又推动了品质改进和合规性提升。在生产製程技术进步和大量新药核准的推动下，该市场展现出成长势头，并预示着一个充满活力的未来。

主要趋势和驱动因素：

口服固体製剂生产市场正经历强劲成长，这主要得益于几个关键趋势和驱动因素。其中一个显着趋势是，由于关键药物的专利到期，对学名药的需求不断增长。这导致学名药生产激增，刺激了市场竞争和创新。此外，药物製剂技术的进步提高了口服固体製剂的生物利用度和稳定性，促使製药公司投资现代化的生产技术。慢性病的日益增多也是关键驱动因素，需要开发有效的口服固体製剂用于长期治疗。全球老龄化人口的成长也推动了市场发展，因为老龄化人口增加了对便捷易用药物剂型的需求。此外，监管机构对口服固体製剂核准的支持正在简化开发流程，并鼓励製药公司扩展产品系列。连续生产流程的日益普及提高了生产效率并降低了营运成本，为市场参与者提供了丰厚的机会。

限制与挑战：

口服固体製剂生产市场面临许多重大限制与挑战。其中一个关键问题是严格的法规环境，要求企业严格遵守相关规定，导致生产成本上升。这种复杂性可能会阻碍新进入者，并限制创新。此外，市场还面临供应链中断的问题，全球事件加剧了这个问题，导致生产延误和成本增加。学名药的日益激烈的竞争给价格和市场份额带来了压力。这种竞争要求企业持续投资研发，以维持竞争优势。所有这些因素共同阻碍了口服固体製剂生产市场的成长和扩张。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 快速起效配方
    • 缓释製剂
    • 咀嚼片
    • 发泡
    • 口溶锭
    • 舌下片
    • 膜衣锭
    • 糖霜片
    • 肠溶片
  • 市场规模及预测：依产品划分
    • 药片
    • 胶囊
    • 粉末
    • 颗粒
    • 锭剂
    • 颗粒
  • 市场规模及预测：依服务划分
    • 配方开发
    • 製程开发
    • 分析测试
    • 监理合规
    • 包装
    • 品质保证
    • 供应链管理
  • 市场规模及预测：依技术划分
    • 压缩
    • 颗粒化
    • 涂层
    • 封装
    • 冷冻干燥
    • 微粉化
    • 喷雾干燥
    • 连续製造
    • 3D列印
  • 市场规模及预测：依应用领域划分
    • 製药
    • 营养保健品
    • 药用化妆品
    • 生物製药
    • 非处方药
    • 处方药
    • 动物用药品
  • 市场规模及预测：依类型
    • 固态剂型
    • 半固态
  • 市场规模及预测：依材料类型划分
    • 原料药（API）
    • 添加剂
    • 粘合剂
    • 崩坏
    • 润滑剂
    • 着色剂
    • 涂层剂
    • 防腐剂
  • 市场规模及预测：依製程划分
    • 湿式製粒
    • 干式製粒
    • 直接压缩
    • 热熔挤出
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 契约製造组织（CMO）
    • 研究与开发实验室

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Catalent Pharma Solutions
  • Lonza Group
  • Aenova Group
  • Recipharm AB
  • Patheon by Thermo Fisher Scientific
  • Almac Group
  • Piramal Pharma Solutions
  • Famar Health Care Services
  • Hovione
  • Capsugel by Lonza
  • NextPharma Technologies
  • Fareva
  • CordenPharma
  • Dishman Carbogen Amcis
  • Delpharm

第九章：关于我们

简介目录
Product Code: GIS34110

Oral Solid Dosage Manufacturing Market is anticipated to expand from $32.3 billion in 2024 to $56.4 billion by 2034, growing at a CAGR of approximately 5.7%. The Oral Solid Dosage Manufacturing Market encompasses the production of pharmaceutical tablets and capsules, renowned for their stability, convenience, and cost-effectiveness. This sector is driven by advancements in drug formulation, process optimization, and regulatory compliance. Innovations in coating technologies, continuous manufacturing, and personalized medicine are shaping the landscape. The rising prevalence of chronic diseases and increasing demand for generic medications are propelling market growth, while sustainability and quality assurance remain pivotal.

The Oral Solid Dosage Manufacturing Market is experiencing robust growth, fueled by technological advancements and increasing demand for efficient drug delivery systems. The immediate-release tablets segment is the top-performing, driven by its widespread use and ease of administration. Sustained-release tablets follow, with their ability to enhance patient compliance and therapeutic efficacy. Capsule formulations, particularly hard capsules, are gaining traction due to their versatility and patient-friendly nature. The market is also seeing a rise in demand for orally disintegrating tablets, catering to populations with swallowing difficulties. Among excipients, binders and fillers are leading, given their critical role in formulation stability and drug release. Coating materials are the second highest-performing sub-segment, as they enhance drug protection and patient compliance. Continuous manufacturing technologies are gaining momentum, offering increased efficiency and reduced production costs. Investments in advanced quality control systems are further propelling market growth, ensuring compliance with stringent regulatory standards.

Market Segmentation
TypeImmediate Release, Modified Release, Chewable Tablets, Effervescent Tablets, Orally Disintegrating Tablets, Sublingual Tablets, Film-Coated Tablets, Sugar-Coated Tablets, Enteric-Coated Tablets
ProductTablets, Capsules, Powders, Granules, Lozenges, Pellets
ServicesFormulation Development, Process Development, Analytical Testing, Regulatory Compliance, Packaging, Quality Assurance, Supply Chain Management
TechnologyCompression, Granulation, Coating, Encapsulation, Lyophilization, Micronization, Spray Drying, Continuous Manufacturing, 3D Printing
ApplicationPharmaceutical, Nutraceutical, Cosmeceutical, Biopharmaceutical, OTC Drugs, Prescription Drugs, Veterinary Medicine
FormSolid, Semi-Solid
Material TypeActive Pharmaceutical Ingredients (APIs), Excipients, Binders, Disintegrants, Lubricants, Colorants, Coating Agents, Preservatives
ProcessWet Granulation, Dry Granulation, Direct Compression, Hot Melt Extrusion
End UserPharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Research and Development Laboratories

Market Snapshot:

The Oral Solid Dosage Manufacturing Market is characterized by a diverse market share distribution, influenced by strategic pricing models and the continuous introduction of innovative products. Key players are focusing on enhancing their portfolios with advanced formulations and delivery technologies. This competitive landscape is further enriched by collaborations and partnerships aimed at expanding product offerings. The pricing strategies are reflective of the value-added benefits these novel products bring, aligning with the evolving demands of healthcare providers and patients alike. Competition within the Oral Solid Dosage Manufacturing Market is intense, with major companies vying for dominance through innovation and strategic mergers. Regulatory influences play a significant role, particularly in regions like North America and Europe, where stringent guidelines shape market dynamics. Companies are compelled to adhere to these regulations, which drive quality enhancements and compliance. The market is poised for growth, supported by technological advancements in manufacturing processes and a robust pipeline of new drug approvals, promising a vibrant future.

Geographical Overview:

The Oral Solid Dosage Manufacturing Market is witnessing notable growth across various regions, each characterized by unique dynamics. North America remains a dominant force, driven by advanced pharmaceutical infrastructure and substantial investments in drug development. The region's focus on innovation and quality in manufacturing processes further solidifies its market leadership. Europe follows closely, with strong regulatory frameworks and a commitment to high manufacturing standards. The region's emphasis on sustainable practices and technological advancements enhances its market position. In Asia Pacific, the market is expanding rapidly, propelled by increasing healthcare investments and a burgeoning pharmaceutical industry. Countries like China and India are emerging as significant players, offering lucrative opportunities due to their large patient populations and cost-effective manufacturing capabilities. Latin America and the Middle East & Africa are emerging markets with growing potential. Latin America benefits from rising healthcare expenditures and improving regulatory environments, while the Middle East & Africa are recognizing the importance of pharmaceutical manufacturing in supporting regional healthcare needs and economic development.

Key Trends and Drivers:

The Oral Solid Dosage Manufacturing Market is experiencing robust growth due to several key trends and drivers. A significant trend is the increasing demand for generic medications, driven by the expiration of patents for major drugs. This has led to a surge in generic drug manufacturing, fostering competition and innovation within the market. Additionally, advancements in drug formulation technologies are enhancing the bioavailability and stability of oral solid dosages, attracting pharmaceutical companies to invest in modern manufacturing techniques. The growing prevalence of chronic diseases is another critical driver, necessitating the development of effective oral solid dosage forms for long-term treatment. The market is also benefiting from the rising global geriatric population, which requires convenient and easy-to-administer medication forms. Furthermore, regulatory support for the approval of oral solid dosage drugs is streamlining the development process, encouraging pharmaceutical firms to expand their product portfolios. The increasing adoption of continuous manufacturing processes is enhancing production efficiency and reducing operational costs, offering lucrative opportunities for market players.

Restraints and Challenges:

The Oral Solid Dosage Manufacturing Market encounters several significant restraints and challenges. A primary concern is the stringent regulatory environment, which necessitates rigorous compliance and increases the cost of production. This complexity can deter new entrants and limit innovation. Additionally, the market faces supply chain disruptions, exacerbated by global events, leading to delays and increased costs. Furthermore, the rising cost of raw materials poses a significant challenge, squeezing profit margins and affecting pricing strategies. The market also grapples with the need for advanced technology and equipment, which demands substantial capital investment and skilled personnel. This requirement can be prohibitive for smaller manufacturers. Lastly, the increasing competition from generic and over-the-counter drugs adds pressure on pricing and market share. This competition necessitates continuous investment in research and development to maintain a competitive edge. These factors collectively impede the growth and expansion of the Oral Solid Dosage Manufacturing Market.

Key Players:

Catalent Pharma Solutions, Lonza Group, Aenova Group, Recipharm AB, Patheon by Thermo Fisher Scientific, Almac Group, Piramal Pharma Solutions, Famar Health Care Services, Hovione, Capsugel by Lonza, NextPharma Technologies, Fareva, CordenPharma, Dishman Carbogen Amcis, Delpharm

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Immediate Release
    • 4.1.2 Modified Release
    • 4.1.3 Chewable Tablets
    • 4.1.4 Effervescent Tablets
    • 4.1.5 Orally Disintegrating Tablets
    • 4.1.6 Sublingual Tablets
    • 4.1.7 Film-Coated Tablets
    • 4.1.8 Sugar-Coated Tablets
    • 4.1.9 Enteric-Coated Tablets
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Tablets
    • 4.2.2 Capsules
    • 4.2.3 Powders
    • 4.2.4 Granules
    • 4.2.5 Lozenges
    • 4.2.6 Pellets
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Formulation Development
    • 4.3.2 Process Development
    • 4.3.3 Analytical Testing
    • 4.3.4 Regulatory Compliance
    • 4.3.5 Packaging
    • 4.3.6 Quality Assurance
    • 4.3.7 Supply Chain Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Compression
    • 4.4.2 Granulation
    • 4.4.3 Coating
    • 4.4.4 Encapsulation
    • 4.4.5 Lyophilization
    • 4.4.6 Micronization
    • 4.4.7 Spray Drying
    • 4.4.8 Continuous Manufacturing
    • 4.4.9 3D Printing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Pharmaceutical
    • 4.5.2 Nutraceutical
    • 4.5.3 Cosmeceutical
    • 4.5.4 Biopharmaceutical
    • 4.5.5 OTC Drugs
    • 4.5.6 Prescription Drugs
    • 4.5.7 Veterinary Medicine
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Solid
    • 4.6.2 Semi-Solid
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Active Pharmaceutical Ingredients (APIs)
    • 4.7.2 Excipients
    • 4.7.3 Binders
    • 4.7.4 Disintegrants
    • 4.7.5 Lubricants
    • 4.7.6 Colorants
    • 4.7.7 Coating Agents
    • 4.7.8 Preservatives
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Wet Granulation
    • 4.8.2 Dry Granulation
    • 4.8.3 Direct Compression
    • 4.8.4 Hot Melt Extrusion
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Pharmaceutical Companies
    • 4.9.2 Contract Manufacturing Organizations (CMOs)
    • 4.9.3 Research and Development Laboratories

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 Process
      • 5.2.1.9 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 Process
      • 5.2.2.9 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 Process
      • 5.2.3.9 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 Process
      • 5.3.1.9 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 Process
      • 5.3.2.9 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 Process
      • 5.3.3.9 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 Process
      • 5.4.1.9 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 Process
      • 5.4.2.9 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 Process
      • 5.4.3.9 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 Process
      • 5.4.4.9 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 Process
      • 5.4.5.9 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 Process
      • 5.4.6.9 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 Process
      • 5.4.7.9 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 Process
      • 5.5.1.9 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 Process
      • 5.5.2.9 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 Process
      • 5.5.3.9 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 Process
      • 5.5.4.9 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 Process
      • 5.5.5.9 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 Process
      • 5.5.6.9 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 Process
      • 5.6.1.9 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 Process
      • 5.6.2.9 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 Process
      • 5.6.3.9 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 Process
      • 5.6.4.9 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 Process
      • 5.6.5.9 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Catalent Pharma Solutions
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Lonza Group
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Aenova Group
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Recipharm AB
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Patheon by Thermo Fisher Scientific
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Almac Group
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Piramal Pharma Solutions
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Famar Health Care Services
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Hovione
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Capsugel by Lonza
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 NextPharma Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fareva
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 CordenPharma
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Dishman Carbogen Amcis
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Delpharm
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us